Quoin Pharmaceuticals Ltd... (QNRX)
0.31
-0.05 (-12.73%)
At close: Feb 28, 2025, 3:59 PM
0.30
-3.94%
After-hours: Feb 28, 2025, 05:53 PM EST
Quoin Pharmaceuticals Ltd. Balance Sheet Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 |
| Cash & Equivalents | 2.4M | 2.86M | 7.48M | 323.83K | 5.24M | 4.77M | 3.96M | 1.63M | 1.01M |
| Short-Term Investments | 8.29M | 9.99M | n/a | n/a | n/a | n/a | 4.03M | 6.41M | 2.01M |
| Long-Term Investments | n/a | n/a | n/a | n/a | 122.18K | 125.51K | 137.69K | 36.38K | 5.14K |
| Other Long-Term Assets | 300K | 383.39K | 50K | -1.94M | -1.02K | n/a | 1.00 | n/a | -1 |
| Receivables | n/a | n/a | n/a | n/a | 77.3K | 57.8K | 70.57K | 172.01K | 48.06K |
| Inventory | n/a | n/a | n/a | n/a | 1.00 | n/a | 1.00 | 1.00 | n/a |
| Other Current Assets | 558.45K | 516.58K | 715.47K | 141.34K | 58.48K | 160.57K | 165.05K | 207.6K | 57.83K |
| Total Current Assets | 11.29M | 13.37M | 8.5M | 465.17K | 5.38M | 4.98M | 8.22M | 8.42M | 3.12M |
| Property-Plant & Equipment | n/a | n/a | n/a | 1.94M | 672.55K | 413.19K | 387.14K | 356.75K | 305.06K |
| Goodwill & Intangibles | 583.33K | 704.56K | 808.6K | 912.65K | 1.02M | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 883.33K | 1.09M | 858.6K | 912.65K | 794.73K | 538.7K | 524.83K | 393.12K | 310.2K |
| Total Assets | 12.17M | 14.46M | 9.36M | 1.38M | 6.17M | 5.52M | 8.75M | 8.81M | 3.43M |
| Account Payables | 526.52K | 605.6K | 923.24K | n/a | 45.74K | 237.37K | 490.55K | 348.95K | 119.76K |
| Deferred Revenue | n/a | -600 | -743.84M | n/a | 1.00 | n/a | n/a | 1.00 | n/a |
| Short-Term Debt | n/a | n/a | 743.84M | 1.21M | 114.65K | n/a | n/a | 15.07K | n/a |
| Other Current Liabilities | 2.96M | 2.76M | -740.39M | 6.62M | 891.72K | 1.07M | 690.17K | 541.49K | 615.26K |
| Total Current Liabilities | 3.58M | 3.53M | 8.7M | 7.99M | 1.05M | 1.31M | 1.18M | 905.51K | 735.02K |
| Long-Term Debt | n/a | n/a | 4.12M | n/a | 196K | n/a | n/a | n/a | n/a |
| Other Long-Term Liabilities | 2.92M | 3.52M | 7.03B | n/a | 628.84K | 485.98K | 2.14M | 503.55K | n/a |
| Total Long-Term Liabilities | 2.92M | 3.52M | 7.03B | n/a | 824.84K | 485.98K | 2.14M | 503.55K | n/a |
| Total Liabilities | 6.51M | 7.05M | 8.7M | 7.99M | 1.88M | 1.8M | 3.32M | 1.41M | 735.02K |
| Total Debt | 3.52K | 4.12K | 743.84M | 1.21M | 310.65K | n/a | n/a | 15.07K | n/a |
| Common Stock | n/a | n/a | n/a | n/a | 100.00 | n/a | n/a | n/a | n/a |
| Retained Earnings | -46.2M | -37.52M | -28.07M | -6.61M | -29.2M | -22.49M | -18.42M | -9.28M | -5.24M |
| Comprehensive Income | -0.00 | -0.00 | 0.00 | 5.14M | 4.79M | 3.3M | 2.7M | 1.62M | 972.49K |
| Shareholders Equity | 5.66M | 7.41M | 657.03K | -6.61M | 4.3M | 3.73M | 5.43M | 7.4M | 2.7M |
| Total Investments | 8.29M | 9.99M | n/a | n/a | 122.18K | 125.51K | 4.17M | 6.44M | 2.02M |